Pharmaceutical Mergers and Acquisitions: What You Need to Know
Stay informed about the latest in drug development with BioPharma Dive’s free newsletter, delivered straight to your inbox. In the […]
Browsing author
Stay informed about the latest in drug development with BioPharma Dive’s free newsletter, delivered straight to your inbox. In the […]
The obesity drug market is currently dominated by two major players: Eli Lilly and Novo Nordisk. Both companies are working […]
A report from the Make America Healthy Again (MAHA) Commission was delayed earlier this month, but leaked documents reveal plans […]
The US Food and Drug Administration (FDA) has given special recognition to a new experimental drug called izalontamab brengitecan (iza-bren). […]
Anne White, the Executive Vice President and President of Lilly Neuroscience at Eli Lilly and Company, will retire at the […]
In this project, ANGLE’s research team will use the Parsortix system to collect cancer cells from the blood of cancer […]
The US Centers for Disease Control and Prevention (CDC) reports that about one in six Americans struggles with substance use […]
AstraZeneca’s journey in lung cancer treatment began in 2003 with a drug called Iressa, which targeted a specific gene mutation […]
The International Council for Harmonisation (ICH) has opened a public consultation on its draft guidelines for managing drug impurities caused […]
Teva Pharmaceuticals has received FDA approval for AJOVY (fremanezumab-vfrm) as a preventive treatment for episodic migraines in children and adolescents […]